Skip to main content
Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.730
-0.190 (-6.51%)
At close: Apr 28, 2026, 4:00 PM EDT
2.721
-0.009 (-0.32%)
Pre-market: Apr 29, 2026, 5:39 AM EDT

Compugen Revenue

In the year 2025, Compugen had annual revenue of $72.76M with 161.14% growth. Compugen had revenue of $67.33M in the quarter ending December 31, 2025, with 4,477.29% growth.

Revenue (ttm)
$72.76M
Revenue Growth
+161.14%
P/S Ratio
3.55
Revenue / Employee
$970,187
Employees
75
Market Cap
258.13M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202572.76M44.90M161.14%
Dec 31, 202427.86M-5.60M-16.72%
Dec 31, 202333.46M25.96M346.12%
Dec 31, 20227.50M1.50M25.00%
Dec 31, 20216.00M4.00M200.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cellectis 79.59M
Editas Medicine 40.52M
C4 Therapeutics 35.95M
Zentalis Pharmaceuticals 26.87M
LENZ Therapeutics 19.09M
Abeona Therapeutics 5.82M
AC Immune 4.51M
Revenue Rankings

CGEN News

More News